Dow Down 0.22% Nasdaq Up 0.14%

More On IMV.V

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

ImmunoVaccine Inc. (IMV.V)

-TSXV
0.97 Down 0.07(6.73%) Aug 22, 3:59PM EDT
Prev Close:1.04
Open:1.05
Bid:0.96
Ask:0.97
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.97 - 1.06
52wk Range:0.24 - 1.50
Volume:163,980
Avg Vol (3m):52,330
Market Cap:77.16M
P/E (ttm):N/A
EPS (ttm):-0.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunovaccine Inc., a clinical-stage biopharmaceutical company, discovers and develops activators of the immune system to treat cancer and prevent infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback